NFE2L2 and Hyperglycemia: Our results show that in-vitro hyperglycemia reduces 1) gastric and duodenal Nrf2, nNOSα and ER alpha protein expression, 2) supplementation of estrogen and/or estrogen receptors restores Nrf2, nNOSα, total nitrite and nitrergic relaxation in hyperglycemic conditions.